Cancer Types: Difference between revisions

#[[AML|Acute Myeloid Leukemia]]

: Squamous cell carcinoma

: Lymphoepithelial carcinoma

: Sinonasal undifferentiated carcinoma

: Adenocarcinoma

: Salivary gland-type carcinomas

: Neuroendocrine tumours

: Benign epithelial tumours

: Schneiderian papillomas

: Respiratory epithelial adenomatoid hamartoma

: Salivary gland-type adenomas

: Soft tissue tumours

: Malignant soft tissue tumours

: Borderline and LMP tumours

: Benign soft tissue tumours

: Tumours of bone and cartilage

: Malignant tumours

: Benign tumours

: Haematolymphoid tumours

: Neuroectodermal tumours

: Germ cell tumours

: Secondary tumours

: Invasive lobular carcinoma

: Tubular carcinoma and cribriform carcinoma

: Carcinoma with medullary features

: Metaplastic carcinoma

: Carcinoma with apocrine differentiation

: Salivary gland/skin adnexal type tumors

: Adenoid cystic carcinoma

: Mucoepidermoid  carcinoma

: Polymorphous carcinoma

: Mucinous carcinoma and carcinoma with

: Ssignet-ring-cell differentiation carcinoma with neuroendocrine features

: Invasive papillary carcinoma

: Invasive micropapillary carcinoma

: Inflammatory carcinoma

: Secretory carcinoma

: Oncocytic carcinoma

: Sebaceous carcinoma

: Lipid-rich carcinoma

: Glycogen-rich clear cell carcinoma

: Acinic cell carcinoma

: Ductal carcinoma in situ

: Intraductal papilloma

: Intraductal papillary carcinoma

: Encapsulated papillary carcinoma

: Solid papillary carcinoma

: Adenosis, sclerosing adenosis and

: apocrine adenosis

: Microglandular adenosis,

: atypical microglandular adenosis and

: microglandular adenosis with carcinoma

: Radial scar and complex sclerosing lesion             

: Tubular adenoma  

: Myoepithelial and epithelial–myoepithelial lesions

: Adenomyoepithelioma and adenomyoepithelioma with carcinoma

: Pseudoangiomatous stromal hyperplasia

: Myofibroblastoma

: Desmoid-type fibromatosis

: Angiosarcoma

: Fibroadenoma

: Phyllodes tumour

: Paget disease

: Diffuse large B-cell lymphoma

: Gynaecomastia

: Carcinoma of the male breast

: BRCA1 and BRCA2 syndromes

: Li-Fraumeni syndrome

'''Hematological and Lymphoid Neoplasms'''

'''Myeloproliferative neoplasms'''

:Chronic myelogenous leukaemia, BCR-ABL1 positive

:Chronic neutrophilic leukaemia

:Polycythaemia vera

:Primary myelofibrosis

:Essential thrombocythaemia

:Chronic eosinophilic leukaemia, NOS

:Mastocytosis

:Cutaneous mastocytosis

:Systemic mastocytosis

:Mast cell leukaemia

:Mast cell sarcoma

:Extracutaneous mastocytoma

:Myeloproliferative neoplasm, unclassifiable

'''Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA,PDGFRB or FGFR1'''

'''Myelodysplastic/myeloproliferative neoplasms'''

:Chronic myelomonocytic leukaemia

:Atypical chronic myeloid leukaemia, BCR-ABL1 negative  

:Juvenile myelomonocytic leukaemia

:Myelodysplastic/myeloproliferative neoplasm, unclassifiable

'''Myelodysplastic syndromes'''

:Myelodysplastic syndromes/neoplasms, overview

:Refractory cytopenia with unilineage dysplasia

:Refractory anaemia with ring sideroblasts

:Refractory cytopenia with multilineage dysplasia  

:Refractory anaemia with excess blasts

:Myelodysplastic syndrome with isolated del(5q)  

:Myelodysplastic syndrome, unclassifiable  

:Childhood myelodysplastic syndrome

:Refractory cytopenia of childhood  

'''Acute myeloid leukaemia (AML) and related precursor neoplasms'''

:AML with recurrent genetic abnormalities

:AML with t(8;21)(q22;q22); RUNX1-RUNX1T1

:AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11

:Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA

:AML with t(9;11)(p22;q23); MLLT3-MLL

:AML with t(6;9)(p23;q34); DEK-NUP214

:AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2);RPN1-EVI1

:AML (megakaryoblastic) with t(1;22)(p13;q13);RBM15-MKL1

:AML with mutated NPM1

:AML with mutated CEBPA

:AML with myelodysplasia-related changes

:Therapy-related myeloid neoplasms

:Acute myeloid leukaemia, NOS

:AML with minimal differentiation

:AML without maturation

:AML with maturation

:Acute myelomonocytic leukaemia

:Acute monoblastic and monocytic leukaemia

:Acute erythroid leukaemia

:Acute megakaryoblastic leukaemia

:Acute basophilic leukaemia

:Acute panmyelosis with myelofibrosis

:Myeloid sarcoma

:Myeloid proliferations related to Down syndrome

:Transient abnormal myelopoiesis

:Myeloid leukaemia associated with Down syndrome

:Blastic plasmacytoid dendritic cell neoplasm  

'''Acute leukaemias of ambiguous lineage'''

:Acute undifferentiated leukaemia

:Mixed phenotype acute leukaemia with t(9;22)(q34;q11.2); BCR-ABL1

:Mixed phenotype acute leukaemia with t(v;11q23); MLL rearranged  

:Mixed phenotype acute leukaemia, B/myeloid, NOS 152

:Mixed phenotype acute leukaemia, T/myeloid, NOS 153

:Mixed phenotype acute leukaemia, NOS - rare types

:Other ambiguous lineage leukaemias

:Natural killer (NK)-cell lymphoblastic leukaemia/lymphoma

'''Precursor lymphoid neoplasms'''

:B lymphoblastic leukaemia/lymphoma, NOS

:B lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities

:B lymphoblastic leukaemia/lymphoma with t(9:22)(q34;q11.2); BCR-ABL1

:B lymphoblastic leukaemia/lymphoma with t(v;11q23); MLL rearranged  

:B lymphoblastic leukaemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)

:B lymphoblastic leukaemia/lymphoma with hyperdiploidy  

:B lymphoblastic leukaemia/lymphoma with hypodiploidy (Hypodiploid ALL)

:B lymphoblastic leukaemia/lymphoma with t(5;14)(q31;q32); IL3-IGH

:B lymphoblastic leukaemia/lymphoma with t(1;19) (q23;p13.3); E2A-PBX1(TCF3-PBX1)

:T lymphoblastic leukaemia/lymphoma

'''Mature B-cell neoplasms'''

:Chronic lymphocytic leukaemia /small lymphocytic lymphoma  

:B-cell prolymphocytic leukaemia

:Splenic marginal zone lymphoma  

:Hairy cell leukaemia

:Splenic B-cell lymphoma/leukaemia, unclassifiable

:Splenic diffuse red pulp small B-cell lymphoma

:Hairy cell leukaemia-variant

:Lymphoplasmacytic lymphoma

:Heavy chain diseases  

:Gamma heavy chain disease  

:Mu heavy chain disease  

:Alpha heavy chain disease  

:Plasma cell neoplasms  

:Monoclonal gammopathy of undetermined significance (MGUS)

:Plasma cell myeloma

:Solitary plasmacytoma of bone  

:Extraosseous plasmacytoma  

:Monoclonal immunoglobulin deposition diseases  

:Extranodal marginal zone lymphoma of mucosa- associated lymphoid tissue (MALT lymphoma)

:Nodal marginal zone lymphoma  

:Follicular lymphoma  

:Primary cutaneous follicle centre lymphoma  

:Mantle cell lymphoma

:Diffuse large B-cell lymphoma (DLBCL), NOS

:T cell/histiocyte-rich large B-cell lymphoma  

:Primary DLBCL of the CNS

:Primary cutaneous DLBCL, leg type  

:EBV positive DLBCL of the elderly  

:DLBCL associated with chronic inflammation

:Lymphomatoid granulomatosis

:Primary mediastinal (thymic) large B-cell lymphoma  

:Intravascular large B-cell lymphoma  

:ALK positive large B-cell lymphoma  

:Plasmablastic lymphoma

:Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease

:Primary effusion lymphoma

:Burkitt lymphoma  

:B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma  

:B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma  

'''Mature T- and NK-cell neoplasms'''

:T-cell prolymphocytic leukaemia

:T-cell large granular lymphocytic leukaemia

:Chronic lymphoproliferative disorder of NK cells

:Aggressive NK cell leukaemia

:Epstein-Barr virus (EBV) positive T-cell lymphoproliferative diseases of childhood  

:Systemic EBV+ T-cell lymphoproliferative disease of childhood  

:Hydroa vacciniforme-like lymphoma  

:Adult T-cell leukaemia/lymphoma

:Extranodal NK/T-cell lymphoma, nasal type

:Enteropathy-associated T-cell lymphoma  

:Hepatosplenic T-cell lymphoma  

:Subcutaneous panniculitis-like T-cell lymphoma  

:Mycosis fungoides

:Sézary syndrome

:Primary cutaneous CD30 positive T-cell lymphoproliferative disorders

:Primary cutaneous peripheral T-cell lymphomas, rare subtypes  

:Primary cutaneous gamma-delta T-cell lymphoma  

:Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma  

:Primary cutaneous CD4 positive small/medium T-cell lymphoma  

:Peripheral T-cell lymphoma, NOS

:Angioimmunoblastic T-cell lymphoma  

:Anaplastic large cell lymphoma, ALK positive  

:Anaplastic large cell lymphoma, ALK negative  

'''Hodgkin lymphoma'''

:Nodular lymphocyte predominant Hodgkin lymphoma  

:Classical Hodgkin lymphoma

:Nodular sclerosis classical Hodgkin lymphoma  

:Mixed cellularity classical Hodgkin lymphoma  

:Lymphocyte-rich classical Hodgkin lymphoma  

:Lymphocyte-depleted classical Hodgkin lymphoma  

'''Immunodeficiency-associated lymphoproliferative disorders'''

:Lymphoproliferative diseases associated with primary immune disorders

:Lymphomas associated with HIV infection  

:Post-transplant lymphoproliferative disorders (PTLD)  

:Plasmacytic hyperplasia and infectious- mononucleosis-like PTLD

:Polymorphic PTLD

:Monomorphic PTLD

:Classical Hodgkin lymphoma type PTLD

:Other iatrogenic immunodeficiency-associated lymphoproliferative disorders

'''Histiocytic and dendritic cell neoplasms'''

:Histiocytic sarcoma

:Tumours derived from Langerhans cells

:Langerhans cell histiocytosis

:Langerhans cell sarcoma  

:Interdigitating dendritic cell sarcoma

:Follicular dendritic cell sarcoma  

:Other rare dendritic cell tumours

:Disseminated juvenile xanthogranuloma

::[[Acute Megakaryoblastic Leukemia (AMKL)]]